Clinical Trial Update: PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN) [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial comparing piperacillin/tazobactam to meropenem for bloodstream infections caused by cephalosporin-resistant Enterobacteriaceae;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Bloodstream Infection

Drugs mentioned

• Meropenem (Meropenem)
• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections | Phase 4 | Status: RECRUITING